602 filings
Page 3 of 31
8-K
rwbsfmxu
1 Feb 22
Results of Operations and Financial Condition
4:25pm
8-K
6qon8oj
11 Jan 22
Results of Operations and Financial Condition
6:45am
8-K/A
8glufhc4jargva3q
4 Nov 21
Completion of Acquisition or Disposition of Assets
4:13pm
8-K
gkmjif1b
2 Nov 21
Results of Operations and Financial Condition
4:16pm
8-K
1j5ce6nmweoeaftoy7ew
1 Oct 21
Other Events
4:53pm
424B7
x082r85movy
1 Oct 21
Prospectus with selling stockholder info
4:52pm
D
g16o4xjb db
23 Sep 21
$2.2B in equity, sold $2.2B, 61 investors
5:09pm
8-K
d5gs9b
21 Sep 21
Completion of Acquisition or Disposition of Assets
12:00am
8-K
vzjtx
10 Sep 21
Entry into a Material Definitive Agreement
4:06pm
424B5
w9i84
9 Sep 21
Prospectus supplement for primary offering
5:07pm
FWP
hhtdtsulm
9 Sep 21
Free writing prospectus
12:00am
424B5
typ0zbus6iflc6g4mhnk
8 Sep 21
Prospectus supplement for primary offering
9:18am
8-K
7fmsg
25 Aug 21
Entry into a Material Definitive Agreement
4:06pm
8-K
r809q7e
12 Aug 21
Term Loan Credit Agreement
4:06pm
8-K
ipma0mdsnb4vsj
27 Jul 21
PerkinElmer to Acquire Antibody and Reagent Leader BioLegend
4:33pm
8-K
uv3i njk8
26 Jul 21
Results of Operations and Financial Condition
6:35am